Literature DB >> 30742355

High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation.

Nima Memaran1, Bianca Borchert-Mörlins1, Bernhard M W Schmidt2, Rizky I Sugianto1, Hannes Wilke1, Ricarda Blöte1, Ulrich Baumann3, Elena Bauer1, Anika von Wick1, Norman Junge3, Christoph Leiskau3, Eva D Pfister3, Daniela Thurn-Valsassina1, Nicolas Richter4, Imeke Goldschmidt3, Anette Melk1.   

Abstract

Cardiovascular (CV) events account for 8%-13% of deaths after liver transplantation (LT) in adulthood. Although CV risk factors (RFs) are present, little is known about the prevalence of subclinical CV target organ damage (TOD) in children after LT. The aim of this prospective observational study was to assess the prevalence of subclinical CV TOD in children after LT and to identify RFs contributing to CV damage as potential targets for clinical intervention. In this study, 104 children after LT (54% female, 46% male; aged 11.5 ± 3.8 years) underwent cross-sectional assessment of subclinical TOD by carotid-femoral pulse wave velocity (PWV), carotid intima-media thickness (IMT), and left ventricular mass index (LVMI). Results were correlated with the presence of CV RFs (obesity, hypertension, dyslipidemia, renal impairment, anemia, and microinflammation). Of the patients, 22% were exposed to 2 CV RFs, and 36% displayed 3 or more CV RFs. Pathological results for PWV, IMT, and LVMI were found in 21.9%, 57.0%, and 11.1% of patients, respectively. In the multivariate analysis, diastolic blood pressure (P = 0.01) and estimated glomerular filtration rate (eGFR; P = 0.03) were independently associated with PWV, eGFR (P = 0.005), and age at LT (P = 0.048) with IMT and body mass index with LVMI (P = 0.004). In conclusion, patients after pediatric LT carry a substantial burden of subclinical CV TOD. Identification of modifiable CV RFs opens opportunities for targeted intervention in order to reduce CV morbidity and mortality in the future.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2019        PMID: 30742355     DOI: 10.1002/lt.25431

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Targeting Calcineurin Inhibitor-Induced Arterial Hypertension in Liver Transplanted Children Using Hydrochlorothiazide.

Authors:  Steffen Hartleif; Hannah Baier; Matthias Kumpf; Rupert Handgretinger; Alfred Königsrainer; Silvio Nadalin; Ekkehard Sturm
Journal:  J Pediatr Pharmacol Ther       Date:  2022-07-06

2.  Incidence of cardiovascular disease and mortality in childhood solid organ transplant recipients: a population-based study.

Authors:  Sandeep Brar; Stephanie N Dixon; J Michael Paterson; Jade Dirk; Emma Hahn; S Joseph Kim; Vicky Ng; Melinda Solomon; Jovanka Vasilevska-Ristovska; Tonny Banh; Paul C Nathan; Rulan S Parekh; Rahul Chanchlani
Journal:  Pediatr Nephrol       Date:  2022-07-18       Impact factor: 3.651

3.  Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life.

Authors:  Luisa Stasch; Johanna Ohlendorf; Ulrich Baumann; Gundula Ernst; Karin Lange; Christiane Konietzny; Eva-Doreen Pfister; Kirsten Sautmann; Imeke Goldschmidt
Journal:  Children (Basel)       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.